Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells

被引:50
作者
May, C
Weigl, L
Karel, A
Hohenegger, M
机构
[1] Med Univ, Inst Pharmacol, Vienna, Austria
[2] Med Univ, Dept Anesthesia & Intens Care Med B, Vienna, Austria
关键词
human skeletal muscle cells; P2Y receptor; ATP; MRS2179; calcium signalling; ERK1/2;
D O I
10.1016/j.bcp.2006.02.003
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
ATP is released at the neuromuscular junction to regulate development and proliferation. The sequential expression of P2X and P2Y receptors has been correlated to these effects in many species and cell lines. We have therefore investigated ATP mediated signalling in differentiated primary human skeletal muscle cells. ATP was capable to trigger Ca2+ transients in these cells via P2Y receptors which were not attributable to Ca2+, influx via P2X receptors. Instead, ATP propagated the formation of inositol phosphate (IP) with an EC50 of 21.3 mu M. The Ca2+, transient provoked by ATP was abrogated roughly 75% by the phospholipase C (PLC) inhibitor, U73122. Interestingly, the ryanodine sensitive Ca2+ pool was not involved in ATP triggered Ca2+ release. On mRNA level and by a pharmacological approach we confirmed the presence of the P2Y(1), P2Y(2), P2Y(4) and P2Y(6) receptors. Substantially, ATP activated IP formation via a P2Y, receptor. In addition, ATP elicited extracellular signal regulated kinase (ERK)1/2 phosphorylation in a time and concentration dependent manner, again mainly via P2Y, receptors. The ATP mediated ERK1/2 phosphorylation was strictly dependent on phospholipase C and P13 kinase activity. Importantly, ATP mediated ERK1/2 phosphorylation. was Ca2+ independent. This observation was corroborated by the finding that conventional protein kinase C inhibitors did not Suppress ATP triggered ERK1/2 phosphorylation. Taken together, these observations highlight the importance of ATP as a co-neurotransmitter at the neuromuscular junction via dual signalling, i.e. IP3 receptor mediated Ca2+, transients and Ca2+, insensitive phosphorylation of ERK1/2. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1497 / 1509
页数:13
相关论文
共 50 条
[1]
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family [J].
Abbracchio, MP ;
Boeynaems, JM ;
Barnard, EA ;
Boyer, JL ;
Kennedy, C ;
Miras-Portugal, MT ;
King, BF ;
Gachet, C ;
Jacobson, KA ;
Weisman, GA ;
Burnstock, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) :52-55
[2]
Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells [J].
Adrian, K ;
Bernhard, MK ;
Breitinger, HG ;
Ogilvie, A .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (01) :127-138
[3]
The formation of skeletal muscle myotubes requires functional membrane receptors activated by extracellular ATP [J].
Araya, R ;
Riquelme, MA ;
Brandan, E ;
Sáez, JC .
BRAIN RESEARCH REVIEWS, 2004, 47 (1-3) :174-188
[4]
P2 nucleotide receptors on C2C12 satellite cells [J].
Banachewicz W. ;
Supłat D. ;
Krzemiński P. ;
Pomorski P. ;
Barańska J. .
Purinergic Signalling, 2005, 1 (3) :249-257
[5]
CHANGES IN THE LEVELS OF INOSITOL PHOSPHATES AFTER AGONIST-DEPENDENT HYDROLYSIS OF MEMBRANE PHOSPHOINOSITIDES [J].
BERRIDGE, MJ ;
DAWSON, RMC ;
DOWNES, CP ;
HESLOP, JP ;
IRVINE, RF .
BIOCHEMICAL JOURNAL, 1983, 212 (02) :473-482
[6]
Boyer JL, 1996, MOL PHARMACOL, V50, P1323
[7]
Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate [J].
Boyer, JL ;
Mohanram, A ;
Camaioni, E ;
Jacobson, KA ;
Harden, TK .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :1-3
[8]
Cloned and transfected P2Y(4) receptors: Characterization of a suramin and PPADS-insensitive response to UTP [J].
Charlton, SJ ;
Brown, CA ;
Weisman, GA ;
Turner, JT ;
Erb, L ;
Boarder, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (07) :1301-1303
[9]
Choi RCY, 2003, J NEUROSCI, V23, P4445
[10]
Reactive blue 2 inhibition of cyclic AMP-dependent differentiation of rat C6 glioma cells by purinergic receptor-independent inactivation of phosphatidylinositol 3-kinase [J].
Claes, P ;
Van Kolen, K ;
Roymans, D ;
Blero, D ;
Vissenberg, K ;
Erneux, C ;
Verbelen, JP ;
Esmans, EL ;
Slegers, H .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (08) :1489-1498